Ortin Global (ORTINGLOBE)

Turnaround

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹15.8
Market Cap₹12.85 Cr
P/E Ratio0
ROCE-25.11%
ROE-46.07%
Dividend Yield0%
Profit Growth-92.65%
Debt/Equity0.81
Sales Growth-80.22%
Promoter Holding1.23%
52-Week Range₹10.66 — ₹19.92
SectorPharmaceuticals & Biotechnology
Book Value₹1.33

Strengths

Concerns

AI Analysis

Let me apply the Graham test first: a company should have positive earnings, a reasonable balance sheet, and a promoter with skin in the game. Ortin Global fails all three. The latest quarter shows sales of ₹0 Cr and a net loss of ₹0 Cr, while trailing sales have collapsed by 66.67%. I don't need a calculator to see that a business with no revenue cannot compound value. The market cap is only ₹14 Cr, but the price-to-book of 5.69 means Mr. Market is asking me to pay almost six times book for a business earning -39.80% on equity and -25.11% on capital employed. That is not investing; it is speculation. Promoter holding of 1.23% is my biggest red flag. If the people running the business own almost nothing, while outsiders own the rest, I have no reason to believe my interests are aligned. Debt/equity of 0.72 is not extreme, but with negative sales and no profit, even moderate debt can become a problem. The reported 61.54% profit growth is misleading; it likely comes from a lower base of losses, not from a durable earnings stream. Piotroski F-Score of 5/9 offers a sliver of hope, but it does not overcome absent sales and poor returns. Benjamin Graham said price is what you pay, value is what you get. Here, I get negative ROE, no dividend, and almost no promoter ownership. At ₹14.79, I would rather wait. A true margin of safety appears only when this company can show real quarterly sales, positive operating cash flow, and a price closer to or below book value. Until then, this is a pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer